University of Michigan and Virginia-founded Everactive has reached its series C target after three tranches.

The eye disease device developer has raised series B funding to advance research originating from University of Colorado's s Sue Anschutz-Rodgers Eye Center.

CWRU‘s pain neurostimulation spinout has secured series BB funding ahead of a 180-patient trial.

OSI has reinvested in the Oxford fusion energy spinout now set to expand its R&D capacity and headcount.

The exosite drug developer has launched publicly to advance research from Harvard University and Salk Institute for Biological Studies.

Stanford-StartX Fund has backed Turing.com in a series B round that boosted the software developer sourcing platform’s overall funding to at least $46m.

Spun out of University of Côte d’Azur and Inserm, InnoSkel expects to fund clinical work to address a form of skeletal dysplasia that causes dwarfism.

Stanford University supplied capital to help its AI cell analysis spinout Deepcell close its second funding round.

The Virginia Tech-allied brain injury diagnosis software company attracted Virginia Tech Carilion Innovation Fund in what appears to be its first round of funding.

ETH Zurich industrial robotics spinout Anybotics has collected series A capital from investors led by Swisscom Ventures.